MSH6 p.Val1078Ile
Variant summary
The NM_000179.3(MSH6):c.3232G>A (p.Val1078Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V1078A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 134855); p.V1078L: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 127582); p.V1078L: Uncertain_significance (ClinVar VariationId 1729213, 1 star); p.V1078= (synonymous): Benign (ClinVar VariationId 3903497, 1 star); p.V1078= (synonymous): Benign/Likely_benign (ClinVar VariationId 924451, 2 stars)
Frequency
Consequence
NM_000179.3 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 5Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- mismatch repair cancer syndrome 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Muir-Torre syndromeInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- breast cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Uncertain_significance. The variant received 1 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PM1Mutational hot spot or critical domain | Missense neighbourhood moderate hotspot (≥2 P/LP within ±8 AA, OR ≥ 2 vs. background) — PM1 supporting; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 7 pathogenic, 9 benign (OR vs. background: 3.9). | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (threshold 0.0001) — PM2 moderate. | ||
| BP4Computational evidence suggests no impact | Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000179.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH6 | MANE Select | c.3232G>A p.Val1078Ile | missense | Exon 5 of 10 | Prot: NP_000170.1 UniProt: | |
MSH6 | c.3328G>A p.Val1110Ile | missense | Exon 6 of 11 | Prot: NP_001393724.1 | ||
MSH6 | c.3238G>A p.Val1080Ile | missense | Exon 5 of 10 | Prot: NP_001393742.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MSH6 | TSL:1MANE Select | c.3232G>A p.Val1078Ile | missense | Exon 5 of 10 | Prot: ENSP00000234420.5 UniProt: | |
MSH6 | TSL:1 | n.*2579G>A | 3_prime_UTR | Exon 4 of 9 | Prot: ENSP00000405294.1 UniProt: | |
MSH6 | TSL:1 | n.*2579G>A | non_coding_transcript_exon | Exon 4 of 9 | Prot: ENSP00000405294.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:33 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 16 | |
AlphaMissense | Benign | 0.075 | |
BayesDel_addAF | Benign | 0.0077 | T |
BayesDel_noAF | Benign | -0.23 | |
CADD | Benign | 18 | |
DANN | Benign | 0.91 | |
DEOGEN2 | Benign | 0.080 | T |
Eigen | Benign | -0.38 | |
Eigen_PC | Benign | -0.20 | |
FATHMM_MKL | Uncertain | 0.82 | D |
FuncVEP CTI | Benign | 0.011 | |
GPN-Star LLR | N/A | -3.2 | |
GPN-Star score | N/A | 3.2 | |
LIST_S2 | Benign | 0.82 | T |
M_CAP | Benign | 0.036 | D |
MetaRNN | Benign | 0.19 | T |
MetaSVM | Benign | -0.65 | T |
Mutation Taster | N/A | 83/17 | polymorphism |
MutationAssessor | Benign | 0.76 | N |
PhyloP100 | Benign | 2.3 | |
popEVE | Benign | -2.8 | |
PrimateAI | Benign | 0.23 | T |
PROVEAN | Benign | -0.61 | N |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.2 | |
REVEL | Benign | 0.15 | |
Sift | Benign | 0.47 | T |
Sift4G | Benign | 0.23 | T |
Varity_R | N/A | 0.062 | |
VESM-3B | Benign | -3.7 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.